{"name":"Prestige Consumer Healthcare","slug":"prestige-consumer-healthcare","ticker":"PBH","exchange":"NYSE","domain":"prestigeconsumerhealthcare.com","description":"Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dr","hq":"Tarrytown, NY, USA","founded":0,"employees":"600","ceo":"","sector":"Consumer Healthcare / OTC","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":47.87,"stockChange":-3.94,"stockChangePercent":-7.6,"marketCap":"$2.3B","metrics":{"revenue":1103606016,"revenueGrowth":-2.4,"grossMargin":57,"rdSpend":0,"netIncome":186500992,"cash":62373000,"dividendYield":0,"peRatio":12.6,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"yahoo_finance","revenue":1137762000,"revenuePeriod":"2025-03-31","revenueHistory":[{"period":"2025-03-31","value":1137762000},{"period":"2024-03-31","value":1125357000},{"period":"2023-03-31","value":1127725000},{"period":"2022-03-31","value":1086812000}],"grossProfit":634463000,"grossProfitHistory":[{"period":"2025-03-31","value":634463000},{"period":"2024-03-31","value":624448000},{"period":"2023-03-31","value":625294000},{"period":"2022-03-31","value":620646000}],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":263932000,"operatingIncome":349241000,"operatingIncomeHistory":[{"period":"2025-03-31","value":349241000},{"period":"2024-03-31","value":342429000},{"period":"2023-03-31","value":347802000},{"period":"2022-03-31","value":330976000}],"netIncome":214605000,"netIncomeHistory":[{"period":"2025-03-31","value":214605000},{"period":"2024-03-31","value":209339000},{"period":"2023-03-31","value":-82306000},{"period":"2022-03-31","value":205381000}],"eps":4.29,"epsHistory":[{"period":"2025-03-31","value":4.29},{"period":"2024-03-31","value":4.17},{"period":"2023-03-31","value":-1.65},{"period":"2022-03-31","value":4.04}],"cash":97884000,"cashHistory":[{"period":"2025-03-31","value":97884000},{"period":"2024-03-31","value":46469000},{"period":"2023-03-31","value":58489000},{"period":"2022-03-31","value":27185000}],"totalAssets":3402218000,"totalLiabilities":1567321000,"totalDebt":1044250000,"equity":1834897000,"operatingCashflow":251515000,"operatingCashflowHistory":[{"period":"2025-03-31","value":251515000},{"period":"2024-03-31","value":248926000},{"period":"2023-03-31","value":229716000},{"period":"2022-03-31","value":259922000}],"capex":-8224000,"capexHistory":[{"period":"2025-03-31","value":-8224000},{"period":"2024-03-31","value":-9550000},{"period":"2023-03-31","value":-7784000},{"period":"2022-03-31","value":-9642000}],"freeCashflow":243291000,"dividendsPaid":null,"buybacks":-51509000,"employees":600,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":69729000,"ebit":72486000,"ebitda":80078000,"period":"2025-12-31","revenue":283444000,"epsBasic":0.98,"netIncome":46696000,"rdExpense":null,"epsDiluted":0.97,"grossProfit":157369000,"operatingIncome":82491000},{"sga":66738000,"ebit":79169000,"ebitda":86832000,"period":"2025-09-30","revenue":274114000,"epsBasic":0.86,"netIncome":42211000,"rdExpense":null,"epsDiluted":0.86,"grossProfit":151579000,"operatingIncome":79670000},{"sga":63393000,"ebit":71980000,"ebitda":79646000,"period":"2025-06-30","revenue":249530000,"epsBasic":0.96,"netIncome":47466000,"rdExpense":null,"epsDiluted":0.95,"grossProfit":140331000,"operatingIncome":71756000},{"sga":64054000,"ebit":84718000,"ebitda":91970000,"period":"2025-03-31","revenue":296518000,"epsBasic":null,"netIncome":50128000,"rdExpense":null,"epsDiluted":null,"grossProfit":170010000,"operatingIncome":100894000},{"sga":64127000,"ebit":91609000,"ebitda":98477000,"period":"2024-12-31","revenue":290317000,"epsBasic":1.23,"netIncome":61032000,"rdExpense":null,"epsDiluted":1.22,"grossProfit":161049000,"operatingIncome":91962000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":1.1,"netIncome":null,"rdExpense":null,"epsDiluted":1.09,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":47.87,"previousClose":51.81,"fiftyTwoWeekHigh":89.37,"fiftyTwoWeekLow":42.73,"fiftyTwoWeekRange":"42.735 - 89.37","fiftyDayAverage":58.56,"twoHundredDayAverage":62.7,"beta":0.4,"enterpriseValue":3468500480,"forwardPE":9.6,"priceToBook":1.24,"priceToSales":2.05,"enterpriseToRevenue":3.14,"enterpriseToEbitda":9.5,"pegRatio":1.71,"ebitda":364984000,"ebitdaMargin":33.1,"freeCashflow":207171120,"operatingCashflow":276633984,"totalDebt":1079289984,"debtToEquity":59,"currentRatio":3.11,"returnOnAssets":6.1,"returnOnEquity":10.3,"analystRating":"1.3 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":6,"targetMeanPrice":76.5,"targetHighPrice":86,"targetLowPrice":65,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":1388102400,"insiderHeldPercent":1.4,"institutionHeldPercent":111.8,"sharesOutstanding":47318730,"floatShares":46642072,"sharesShort":2920009,"shortRatio":5.64,"shortPercentOfFloat":6.2,"epsTrailing":3.79,"epsForward":4.99,"revenuePerShare":22.52,"bookValue":38.66,"officers":[{"age":61,"name":"Mr. Ronald M. Lombardi CPA","title":"Chairman, President & CEO"},{"age":49,"name":"Ms. Christine  Sacco CPA","title":"CFO & COO"},{"age":60,"name":"Mr. William C. P'Pool J.D.","title":"Senior VP, General Counsel & Corporate Secretary"},{"age":63,"name":"Mr. Adel  Mekhail","title":"Executive Vice President of Marketing & Sales"},{"age":63,"name":"Mr. Jeffrey  Zerillo","title":"Senior Vice President of Operations"},{"age":null,"name":"Mr. Philip David Terpolilli C.F.A.","title":"Director of Investor Relations"},{"age":null,"name":"Dean  Siegal","title":"Director of Communications"},{"age":null,"name":"Mr. Jose Luis Rosado","title":"Senior Vice President of Quality & Regulatory Affairs"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"http://ir.prestigebrands.com/phoenix.zhtml?c=182173&p=irol-irHome","website":"https://www.prestigebrands.com","phone":"914 524 6800"}}